Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

RVPH Stock Annual Income Statement. Download in Excel

Reviva Pharmaceuticals Holdings Inc. logo

Reviva Pharmaceuticals Holdings Inc.

Sector: Manufacturing   

Industry: Medicinal and Botanical Manufacturing

1.34
 
USD
  
-0.16
  
(-10.67%)
Previous close: 1.5  Open: 1.5  Bid: 1.34  Ask: 1.36
52 week range    
0.60   
   5.67
Mkt Cap: 47 M  Avg Vol (90 Days): 1,721,944
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Sunday 22nd December 2024

Stock Rankings

33
MarketXLS Rank
40
Value
38
Technical
21
Quality
How are these ranks calculated?
Search for a stock

Financials

RVPH Income Statement

Annual
Invalid dateFeb-19Feb-20Dec-20Dec-21Dec-22Dec-23
AccretionOnPreferredStock-650811.01 M
Basic EPS from continuing operations-0.21-1.24-1.25-1.65
Basic EPS total-0.21-1.24-1.25-1.65
Basic weighted shares outstanding2 M3 M3 M20 M24 M
Depreciation591.0
DepreciationAndAmortization591.0
Diluted EPS total-0.04-0.21-1.24-1.25-1.65
Diluted weighted shares outstanding14 M3 M3 M20 M24 M
GainOnSaleOfSecurity-2579.02 M-194709.0-239216.0
GeneralAndAdministrativeExpense2 M5 M5 M8 M
Income before tax574131.0617903.0-4 M-9 M-28 M-39 M
Income taxes800.06004.020777.016949.0
Interest income729499.02 M105183.0
InterestExpenseNonOperating-1 M1 M2414.0
MinorityInterests5 M
MiscOtherSpecialCharges105183.0-2414.0-194709.0-239216.0
Net income from total operations574131.0617903.0-4 M-9 M-28 M-39 M
NetIncomeCommonStockholders574131.0617903.0-4 M-9 M-28 M-39 M
NetIncomeContinuousOperations574131.0617903.0-4 M-9 M-28 M-40 M
NetNonOperatingInterestIncomeExpense729499.01 M-1 M-182802.0
NetOperatingInterestIncomeExpense729499.0
Normalized income-7 M
Operating income-152789.0-724740.0-2 M-10 M-28 M-40 M
Operating income before depreciation (EBITDA)574131.0-706032.0-2 M-9 M-28 M-40 M
OperatingExpense-152789.0724740.02 M10 M28 M40 M
Other income net2579.0-18708.0-105183.0-2 M-194709.0239216.0
OtherGandA2 M5 M5 M8 M
OtherOperatingExpenses152789.0724740.028 M40 M
OtherunderPreferredStockDividend-650811.01 M
PreferredStockDividends-650811.01 M
Research & development expense295150.05 M23 M31 M
ResearchExpense295150.05 M23 M31 M
Selling Gen & administrative expense2 M5 M5 M8 M
Total Income available for interest expense (EBIT)574131.0-706032.0-2 M-9 M-28 M-40 M
Total common shares outstanding8 M8 M9 M15 M20 M28 M
Total net income574131.0617903.0-4 M-9 M-28 M-39 M
Total ordinary shares33 M33 M33 M33 M33 M33 M
TotalExpenses-152789.0724740.02 M10 M28 M40 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University